1. A Platinum Resistance-Related lncRNA Signature for Risk Classification and Prognosis Prediction in Patients with Serous Ovarian Cancer
   Yan Zhu et al, 2022, Journal of Oncology CrossRef
2. Analysis of a Long Non-coding RNA associated Signature to Predict Survival in Patients with Bladder Cancer
   Wenwen Zhong et al, 2022, Cureus CrossRef
3. Finding lncRNA-protein Interactions Based on Deep Learning with Dual-net Neural Architecture
   Peng Lihong et al, 2022, IEEE/ACM Transactions on Computational Biology and Bioinformatics CrossRef
4. Long Non-coding RNAs Involved in Resistance to Chemotherapy in Ovarian Cancer
   Cecilie Abildgaard et al, 2020, Frontiers in Oncology CrossRef
5. The Interplay between Long Noncoding RNAs and Proteins of the Epigenetic Machinery in Ovarian Cancer
   Naiade Calanca et al, 2020, Cancers CrossRef
6. Leveraging Genomics, Transcriptomics, and Epigenomics to Understand the Biology and Chemoresistance of Ovarian Cancer
   Sandra Muñoz-Galván et al, 2021, Cancers CrossRef
7. (In)Distinctive Role of Long Non-Coding RNAs in Common and Rare Ovarian Cancers
   Maja Sabol et al, 2021, Cancers CrossRef
8. Computational identification and clinical validation of a novel risk signature based on coagulation-related lncRNAs for predicting prognosis, immunotherapy response, and chemosensitivity in colorectal cancer patients
   Fang Zhang et al, 2023, Frontiers in Immunology CrossRef
9. The Long Non-Coding RNA SNHG12 as a Mediator of Carboplatin Resistance in Ovarian Cancer via Epigenetic Mechanisms
   Cecilie Abildgaard et al, 2022, Cancers CrossRef
10. The Non-Coding RNA GAS5 and Its Role in Tumor Therapy-Induced Resistance
    George I. Lambrou et al, 2020, International Journal of Molecular Sciences CrossRef